P D Markham - JoVE Visualize

Showing results (51-60 of 70) with videos related to

Pageof 7

Sort By:

Lancet (London, England)|December 22, 1984

HTLV-III in symptom-free seronegative personsS Z Salahuddin, J E Groopman, P D Markham, et al.

Developments in Biological Standardization|January 1, 1989

Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6)D V Ablashi, P Lusso, C L Hung, et al.

Lancet (London, England)|September 21, 1985

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivoS Broder, R Yarchoan, J M Collins, et al.

Blood|February 3, 1998

gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?V Fiorelli, R Gendelman, M C Sirianni, et al.

Journal of Experimental Pathology|January 1, 1987

Presence of HTLV-III in tears and cells from the eyes of AIDS patientsD V Ablashi, S Sturzenegger, E A Hunter, et al.

International Journal of Cancer|November 15, 1988

Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6)D V Ablashi, P Lusso, C L Hung, et al.

JAMA|October 18, 1985

HTLV-III infection among health care workers. Association with needle-stick injuriesS H Weiss, W C Saxinger, D Rechtman, et al.

JAMA|March 15, 1985

Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDSR R Redfield, P D Markham, S Z Salahuddin, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991

Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primatesA Hosmalin, P L Nara, M Zweig, et al.

AIDS (London, England)|January 11, 2000

Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaquesL J Patterson, B Peng, A G Abimiku, et al.

Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:

Pageof 7

Lancet (London, England)|December 22, 1984

HTLV-III in symptom-free seronegative personsS Z Salahuddin, J E Groopman, P D Markham, et al.

Developments in Biological Standardization|January 1, 1989

Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6)D V Ablashi, P Lusso, C L Hung, et al.

Lancet (London, England)|September 21, 1985

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivoS Broder, R Yarchoan, J M Collins, et al.

Blood|February 3, 1998

gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?V Fiorelli, R Gendelman, M C Sirianni, et al.

Journal of Experimental Pathology|January 1, 1987

Presence of HTLV-III in tears and cells from the eyes of AIDS patientsD V Ablashi, S Sturzenegger, E A Hunter, et al.

International Journal of Cancer|November 15, 1988

Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6)D V Ablashi, P Lusso, C L Hung, et al.

JAMA|October 18, 1985

HTLV-III infection among health care workers. Association with needle-stick injuriesS H Weiss, W C Saxinger, D Rechtman, et al.

JAMA|March 15, 1985

Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDSR R Redfield, P D Markham, S Z Salahuddin, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991

Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primatesA Hosmalin, P L Nara, M Zweig, et al.

AIDS (London, England)|January 11, 2000

Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaquesL J Patterson, B Peng, A G Abimiku, et al.

Pageof 7